Wise Guy Reports


Wise Guy Reports press releases

  • This report provides comprehensive information on the current therapeutic developmental pipeline of Almirall, S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

  • This report provides comprehensive information on the current therapeutic developmental pipeline of Regeneron Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

  • This report provides comprehensive information on the current therapeutic developmental pipeline of Emergent BioSolutions Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

  • This report provides comprehensive information on the current therapeutic developmental pipeline of Humabs BioMed SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

  • This report provides comprehensive information on the current therapeutic developmental pipeline of Lipicard Technologies Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

  • This report provides comprehensive information on the current therapeutic developmental pipeline of Gilead Sciences, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

  • The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

  • Gonorrhea - Pipeline Review, H1 2015SummaryGlobal Markets Direct’s, ‘Gonorrhea - Pipeline Review, H1 2015’, provides an overview of the Gonorrhea’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gonorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and...

  • The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

  • The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

  • Thymus Cancer - Pipeline Review, H1 2015SummaryGlobal Markets Direct’s, ‘Thymus Cancer - Pipeline Review, H1 2015’, provides an overview of the Thymus Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thymus Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and...

  • This report provides comprehensive information on the therapeutic development for Salivary Gland Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Salivary Gland Cancer and special features on late-stage and discontinued projects.

  • Oropharyngeal Cancer - Pipeline Review, H1 2015SummaryGlobal Markets Direct’s, ‘Oropharyngeal Cancer - Pipeline Review, H1 2015’, provides an overview of the Oropharyngeal Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Oropharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along...

  • This report is the third in a series of three in which the world's top 40 producers of nonwovens are profiled.   CLICK ON THE LINK TO PURCHASE THIS REPORT :https://wiseguyreports.com/reports/the-world-nonwovens-industry-part-3-ten-smaller-producers-part-3-of-3-2014-15     The report provides updated information and data about the activities, investments, and marketing and product strategies of Andrew Industries, Hassan Group, Jofo Group, Mogul, Nan Liu Enterprise, Precision Custom...

  • This report provides information on the latest developments in composites, fibres for protective apparel, graphene coatings, inks for wearable electronics, medical textiles, nanocoatings, nonwovens, piezoelectric fabrics, protective apparel and wearable technology.   CLICK ON THE LINK TO PURCHASE THIS REPORT :https://wiseguyreports.com/reports/technical-textile-markets-product-developments-and-innovations-1st-quarter-2015 The report includes news from the following innovative companies and...

  • Man-made fibre production in Japan declined in 2014 to its second lowest level on record, and mill consumption of man-made fibre for industrial textile production fell to its third lowest level in ten years. There were some bright spots, however.

  • These companies supply a variety of technical textile products for specialist

  • The report contains insight and analysis of developments in a wide range of companies, other organisations involved in the sector and events, including Advanced

  • This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.

  • This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.